-
-
-
-
-
-
-
Amgen (AMGN) plans between $6 billion and $7 billion in share repurchases in 2022
-
-
-
-
-
-
-
Amgen Reports Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
Amgen Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Amgen Reports Third Quarter 2017 Financial Results
-
-
-
-
-
-
-
Amgen's 2015 Revenues Increased 8 Percent To $21.7 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $10.38
-
-
-
-
-
-
-
Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)
-
-
-
-
-
-
-
Oscar Gruss Starts Amgen (AMGN) at Buy; Some Biomedical Tender(ness)
-
77,123 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All